About Timesulin
Timesulin is a Healthcare company based in London (United Kingdom) founded in 2010, and was acquired by Bigfoot Biomedical in June 2017. Replacement cap for Insulin pens to enhance Medication adherence. The company has 1 employees. Timesulin offers products and services including Timesulin. Its focus areas include HealthTech, Disease Self Management, Medication Adherence and Device. Its legal entity is PATIENTS PENDING LTD.
Company details
Timesulin was founded in 2010 in London, United Kingdom, and operates in the medical device sector focused on diabetes management. A replacement cap compatible with major insulin pens is offered, featuring a built-in alarm to indicate time elapsed since the last injection. This device addresses concerns over missed or duplicate doses. The cap includes a non-replaceable battery designed to last 12 months.
- Headquarters London, United Kingdom
- Employees 1
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website timesulin.com
- Social LinkedIn X Facebook
- Acquired by Bigfoot Biomedical (Jun 2017)
- Legal Name Patients Pending Ltd
- Date of Incorporation 21 Sep, 2010
- Jurisdiction LONDON, ENGLAND
- Investors
- Employee Count1
- Acquired byBigfoot Biomedical
(Jun 2017)
Products & Services of Timesulin
Timesulin offers a comprehensive portfolio of products and services, including Timesulin.
Provided access to private company data for investment purposes
Investors in Timesulin
Timesulin has secured backing from 1 investor. Prominent investors backing the company include Bigfoot Biomedical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of a closed-loop automated insulin delivery system | 2014 | bigfootbiomedical.com | Milpitas, United States |
Investor details for Timesulin
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Timesulin
2 dated milestones of Timesulin across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Timesulin is founded.
- Exit Acquired by Bigfoot Biomedical.
Web traffic of Timesulin
Websites that share an audience with Timesulin (timesulin.com).
Websites whose visitors overlap most with Timesulin. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| diabetesmine.com | 100% | View details | |||
| pendiq.com | 93% | View details | |||
diabetesstopshere.org | diabetesstopshere.org | 92% | – | ||
diabetes.sanofi.us | diabetes.sanofi.us | 88% | – | ||
blogs.diabetes.org.uk | blogs.diabetes.org.uk | 88% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Timesulin
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Timesulin
Timesulin was founded in 2010.
Timesulin is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Timesulin has 1 employees.
Timesulin was founded in 2010 in London, United Kingdom, and operates in the medical device sector focused on diabetes management. A replacement cap compatible with major insulin pens is offered, featuring a built-in alarm to indicate time elapsed since the last injection. This device addresses concerns over missed or duplicate doses. The cap includes a non-replaceable battery designed to last 12 months.
Timesulin offers Timesulin.
Timesulin has 1 investor. Key investors include Bigfoot Biomedical.
Timesulin operates through Patients Pending Ltd.
Yes. Timesulin was acquired by Bigfoot Biomedical in June 2017.